Journal of Forensic and Legal Medicine
Volume 16, Issue 7 , Pages 369-374 , October 2009

Sudden death and the forensic evaluation of neurocutaneous syndromes

  • Lisbeth Jensen, MD (Forensic Pathologist)

      Affiliations

    • Discipline of Pathology, Level 3 Medical School North Building, The University of Adelaide, Frome Road, Adelaide 5005, Australia
    • Department of Forensic Medicine, University of Aarhus, Aarhus, Denmark
    • ,
  • Karen J. Heath, MBBS (Forensic Pathologist)

      Affiliations

    • Forensic Science, SA, Adelaide, Australia
    • ,
  • Grace Scott, MBBS (Neuropathologist)

      Affiliations

    • Hanson Institute for Neurological Diseases, Adelaide, Australia
    • ,
  • Roger W. Byard, MBBS MD (Professor of Pathology)

      Affiliations

    • Discipline of Pathology, Level 3 Medical School North Building, The University of Adelaide, Frome Road, Adelaide 5005, Australia
    • Corresponding Author InformationCorresponding author. Tel.: +618 8303 5441; fax: +618 8303 4408.

Received 2 May 2008 ,Accepted 2 April 2009.

References 

  1. Miller VS, Roach ES. Neurocutaneous syndromes. Ch 69. In:  Bradley WG editors. Neurology in clinical practice. 3rd ed.. Boston: Butterworth–Heinemann; 2000;p. 1665–1700
  2. Gomez MR. Neurocutaneous diseases. Ch 9. In:  Bradley WG editors. Neurology in clinical practice. 2nd ed.. Boston: Butterworth–Heinemann; 1996;p. 1561–1581
  3. Herron J, Darrah R, Quaghebeur G. Intra-cranial manifestations of the neurocutaneous syndromes. Clin Radiol. 2000;55:82–98
  4. Salih MA, Murshid WR, Zahraa JN, et al. Congenital and genetic cerebrovascular anomalies as risk factors for stroke in Saudi children. Saudi Med J. 2006;27(Suppl. 1):S53–S60
  5. Byard RW, Schliebs J, Koszyca BA. Osler–Weber–Rendu syndrome – pathological manifestations and autopsy considerations. J Forensic Sci. 2001;46:698–701
  6. Burns AJ, Kaplan LC, Mulliken JB. Is there an association between hemangioma and syndromes with dysmorphic features?. Pediatrics. 1991;88:1257–1267
  7. Mulliken JB. Cutaneous vascular anomalies. Semin Vasc Surg. 1993;6:204–218
  8. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg. 1982;69:412–422
  9. Finn MC, Glowacki J, Mulliken JB. Congenital vascular lesions: clinical application of a new classification. J Pediatr Surg. 1983;18:894–900
  10. Heyer GL, Millar WS, Ghatan S, Garzon MC. The neurologic aspects of PHACE: case report and review of the literature. Pediatr Neurol. 2006;35:419–424
  11. Glowacki J, Mulliken JB. Mast cells in hemangiomas and vascular malformations. Pediatrics. 1982;70:48–51
  12. Cohen MM. Vascular update: morphogenesis, tumors, malformations, and molecular dimensions. Am J Med Genet. 2006;140:2013–2038
  13. Di Rocco C, Tamburrini G. Sturge-Weber syndrome. Childs Nerv Syst. 2006;22:909–921
  14. Guermazi A, De Kerviler E, Zagdanski A-M, Frija J. Diagnostic imaging of choroid plexus disease. Clin Radiol. 2000;55:503–516
  15. Tallman B, Tan OT, Morelli JG, et al. Location of port-wine stains and the likelihood of ophthalmic and/or central nervous system complications. Pediatrics. 1991;87:323–327
  16. Kossoff EH, Buck C, Freeman JM. Outcomes of 32 hemispherectomies for Sturge–Weber syndrome worldwide. Neurology. 2002;59:1735–1738
  17. Plauchu H, de Chadarevian J-P, Bideau A, Robert J-M. Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. Am J Med Genet. 1989;32:291–297
  18. Kjeldsen AD, Vase P, Green A. Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients. J Int Med. 1999;245:31–39
  19. Shovlin CL, Hughes JM, Tuddenham EG, et al. A gene for hereditary haemorrhagic telangiectasia maps to chromosome 9q3. Nat Genet. 1994;6:205–209
  20. McDonald MT, Papenberg KA, Ghosh S, et al. A disease locus for hereditary haemorrhagic telangiectasia maps to chromosome 9q33-34. Nat Genet. 1994;6:197–204
  21. McAllister KA, Grogg KM, Johnson DW, et al. Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet. 1994;8:345–351
  22. Johnson DW, Berg JN, Gallione CJ, et al. A second locus for hereditary hemorrhagic telangiectasia maps to chromosome 12. Genome Res. 1995;5:21–28
  23. Shovlin CL, Guttmacher AE, Buscarini E, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu–Osler–Weber syndrome). Am J Med Genet. 2000;91:66–67
  24. Haitjema T, Disch F, Overtoom TThC, Westermann CJJ, Lammers J-WJ. Screening family members of patients with hereditary hemorrhagic telangiectasia. Am J Med. 1995;99:519–524
  25. Willemse RB, Mager JJ, Westermann CJJ, Overtoom TTC, Mauser H, Wolbers JG. Bleeding risk of cerebrovascular malformations in hereditary hemorrhagic telangiectasia. J Neurosurg. 2000;92:779–784
  26. Román G, Fisher M, Perl DP, Poser CM. Neurological manifestations of hereditary hemorrhagic telangiectasia (Rendu–Osler–Weber disease): report of 2 cases and review of the literature. Ann Neurol. 1978;4:130–134
  27. Cohen MM. Klippel–Trenaunay syndrome. Am J Med Genet. 2000;93:171–175
  28. Jacob AG, Driscoll DJ, Shaughnessy WJ, Stanson AW, Clay RP, Gloviczki P. Klippel–Trenaunay syndrome: spectrum and management. Mayo Clin Proc. 1998;73:28–36
  29. Baskerville PA, Ackroyd JS, Browse NL. The etiology of the Klippel–Trenaunay syndrome. Ann Surg. 1985;202:624–627
  30. Nathan N, Thaller SR. Sturge–Weber syndrome and associated congenital vascular disorders: a review. J Craniofac Surg. 2006;17:724–728
  31. Williams DW, Elster AD. Cranial CT and MR in the Klippel–Trenaunay–Weber syndrome. Am J Neuroradiol. 1992;13:291–294
  32. Petzold A, Bischoff C, Conrad B. Repetitive cerebral bleeding in an adult with Klippel–Trénaunay syndrome (letter). J Neurol. 2000;247:389–391
  33. Huiras EE, Barnes CJ, Eichenfield LF, Pelech AN, Drolet BA. Pulmonary thromboembolism associated with Klippel–Trenaunay syndrome. Pediatrics. 2005;116:e596–e600
  34. Byard RW, Cutz E. Sudden and unexpected death in infancy and childhood due to pulmonary thromboembolism. Arch Pathol Lab Med. 1990;114:142–144
  35. Byard RW, Burrows PE, Izakawa T, Silver MM. Diffuse infantile haemangiomatosis: clinicopathological features and management problems in five fatal cases. Eur J Pediatr. 1991;150:224–227
  36. Palau F, Espinós C. Autosomal recessive cerebellar ataxias. Orphanet J Rare Dis. 2006;1:47
  37. Cabana MD, Crawford TO, Winkelstein JA, Christensen JR, Lederman HM. Consequences of the delayed diagnosis of ataxia-telangiectasia. Pediatrics. 1998;102:98–100
  38. Crawford TO, Skolasky RL, Fernandez R, Rosquist KJ, Lederman HM. Survival probability in ataxia telangiectasia. Arch Dis Child. 2006;91:610–611
  39. Amromin GD, Boder E, Teplitz R. Ataxia-telangiectasia with a 32 year survival. A clinicopathological report. J Neuropathol Exp Neurol. 1979;38:621–643
  40. Li A, Swift M. Mutations at the ataxia-telangiectasia locus and clinical phenotypes of A–T patients. Am J Med Genet. 2000;92:170–177
  41. Su Y, Swift M. Mortality rates among carriers of ataxia-telangiectasia mutant alleles. Ann Int Med. 2000;133:770–778
  42. Friedrich CA. Von Hippel-Lindau syndrome. A pleomorphic condition. Cancer. 1999;86:2478–2482
  43. Maher ER, Yates JR, Harries R, et al. Clinical features and natural history of von Hippel-Lindau disease. Quart J Med. 1990;77:1151–1163
  44. Friedrich CA. Genotype–phenotype correlation in von Hippel-Lindau syndrome. Human Mol Genet. 2001;10:763–767
  45. Melmon KL, Rosen SW. Lindau’s disease. Review of the literature and study of a large kindred. Am J Med. 1964;36:595–617
  46. Glasker S, Van V. Risk of hemorrhage in hemangioblastomas of the central nervous system. Neurosurgery. 2005;57:71–76
  47. Kim JM, Cheong JH, Bak KH, Kim CH, Park DW, Oh YH. Congenital supratentorial hemangioblastoma as an unusual cause of simultaneous supra- and infratentorial intracranial hemorrhage: case report. J Neuro-Oncol. 2006;77:59–63
  48. Cohen MM. Causes of premature death in Proteus syndrome. Am J Med Genet. 2001;101:1–3
  49. Cohen MM. Proteus syndrome: an update. Am J Med Genet. 2005;137C:38–52
  50. Treves F. The elephant man and other reminiscences. London: Cassell; 1923;
  51. Biesecker LG, Happle R, Mulliken JB, et al. Proteus syndrome: diagnostic criteria, differential diagnosis, and patient evaluation. Am J Med Genet. 1999;84:389–395
  52. Rizzo R, Pavone L, Sorge G, Parano E, Baraitser M. Proteus syndrome: report of a case with severe brain impairment and fatal course. J Med Genet. 1990;27:399–402
  53. Horie Y, Fujita H, Mano S, Kuwajima M, Ogawa K. Regional Proteus syndrome: report of an autopsy case. Pathol Int. 1995;45:530–535
  54. Dayani PN, Sadun AA. A case report of Wyburn-Mason syndrome and review of the literature. Neuroradiology. 2007;49:445–446
  55. Lester J, Ruano-Calderon LA, Gonzalez-Olhovich I. Wyburn-Mason syndrome. J Neuroimag. 2005;15:284–285

PII: S1752-928X(09)00057-2

doi: 10.1016/j.jflm.2009.04.004

Journal of Forensic and Legal Medicine
Volume 16, Issue 7 , Pages 369-374 , October 2009

Article Tools

* Image Usage & Resolution